TYR and neoplasm: We have confirmed that these TYR-catalyzed in-situ formed PRTOACs could effectively degrade overexpressed TYR in the melanocytes and subsequently decrease the melanin levels for alleviating skin hyperpigmentation within 48 h on a mouse model.